SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

AST Spacemobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an extensive IP and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

AST SpaceMobile is at a critical inflection point as the community focuses on the upcoming launch of BlueBird 7 and the company's commitment to ramping up satellite production cadence to meet aggressive 2026 deployment targets. Investors are actively debating the impact of recent insider selling against the backdrop of significant contracted revenue and institutional backing, with sentiment split between those viewing current volatility as a strategic entry point and others expressing skepticism over execution risks.

RaveDAO is a global community uniting music, technology, and purpose. Since their first sold-out event at Dubai 2024, they have expanded across Europe, the Middle East, North America, and Asia, hosting world-class experiences with over 100,000 total attendees and 3,000+ attendees for each event.  RaveDAO has worked with top-tier artists like Vintage Culture, Don Diablo, Chris Avantgarde, Lilly Palmer, MORTEN, Bassjackers, and GENESI and has support from Binance, OKX, Bitget, and Polygon. RaveDAO is redefining live entertainment in Web3 and has active partnerships with 1001Tracklists, AMF, and Warner Music.  Beyond the dance floor, RaveDAO channels energy and attention toward impact. In 2025 alone, proceeds from its events helped restore sight to 400+ cataract patients in Nepal and fund over 150 meditation programs across the U.S.

RaveDAO

RaveDAO is experiencing extreme volatility and intense community debate after a massive surge and subsequent sharp decline, with investors actively discussing potential market manipulation and the risks of holding tokens following accusations of a rug pull. The community remains deeply divided, with some traders hunting for a bounce while others warn of a total collapse and criticize the project's circulating supply structure.

Critical Metals Corp. engages in the mining, exploration, and development of lithium metals. It owns Wolfsberg Project and Tanbreez Project. The company was founded on October 24, 2022 and is headquartered in British Virgin Islands.

Critical Metals Corp.

Critical Metals Corp. is trending as investors rally around Greenland's approval of the company's increased 92.5% stake in the Tanbreez rare earth deposit, a move many believe de-risks the asset and bolsters Western mineral supply chain security. The community is actively debating potential short squeeze dynamics and arguing that the current valuation fails to fully account for the project's strategic significance and long-term earnings potential.

Daddy Darth Sidious

SIDIOUS is gaining traction alongside DARTH as part of a themed 'Daddy Darth' sector, with the community actively promoting these nano-cap tokens as speculative weekend runners. Investors are debating the risks of these low-liquidity assets while frequently rotating profits between related tokens in hopes of catching a breakout.

Definium Therapeutics, Inc. operates as clinical stage biopharmaceutical company, which engages in developing novel product candidates to treat brain health disorders. The company was founded by Stephen L. Hurst, Scott M. Freeman, Leonard Latchman and Jamon Alexander Rahn on July 26, 2010 and is headquartered in New York, NY.

Definium Therapeutics Inc.

Definium Therapeutics is experiencing intense market interest following a new executive order that fast-tracks the regulatory review process for psychedelic-based mental health treatments. Community discussions are split between excitement over potential fast-track vouchers and long-term pipeline readouts, and deep skepticism rooted in the company's past management controversies and concerns regarding potential share dilution.

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly on May 10, 1876 and is headquartered in Indianapolis, IN.

Lilly(Eli) & Co

Eli Lilly is experiencing significant market attention following its latest Phase 3 trial data for retatrutide, which demonstrated substantial weight loss and A1C reduction in type 2 diabetes patients without reaching a plateau. While the company's long-term dominance in the obesity and diabetes sector remains a core talking point, investors are closely monitoring competitive pressure from Novo Nordisk and regulatory scrutiny regarding potential safety profiles.

Chainlink is the industry-standard decentralized oracle network that solves the "oracle problem" by connecting smart contracts with real-world data. Blockchains cannot access external information on their own, so Chainlink acts as a secure bridge, enabling smart contracts to react to real-world events using verified, tamper-proof data. It is widely considered one of the first decentralized oracle networks and is the market leader in bringing off-chain data on-chain.  The platform operates through a decentralized network of nodes that fetch, validate, and deliver data to smart contracts. When a contract requests information like a stock price, a committee of independent nodes retrieves and aggregates the data to reach consensus, then delivers a single trustworthy answer. Chainlink offers a suite of services including Data Feeds for asset prices, CCIP for cross-chain token transfers and messaging, Automation for triggering smart contract functions, and Proof of Reserve for verifying asset collateralization.  Chainlink has established itself as critical infrastructure for both DeFi and institutional adoption, with partnerships including Swift, Euroclear, Mastercard, UBS, ANZ, Fidelity International, and J.P. Morgan. Its institutional products include the Chainlink Runtime Environment for tokenized asset workflows, Confidential Compute for privacy-preserving computation, and the Automated Compliance Engine for embedding regulatory rules into smart contracts.  The LINK token is the native asset used to pay node operators for services, fund subscription accounts, and incentivize network security through staking. Node operators stake LINK as collateral, which can be slashed if they provide inaccurate data. Chainlink was co-founded in 2017 by Sergey Nazarov and Steve Ellis, who co-authored the white paper with Ari Juels, and raised $32 million in its September 2017 ICO.

ChainLink

Chainlink is garnering attention as the infrastructure layer for institutional finance, highlighted by the integration of SIX Group's massive real-time equities data onto the blockchain. The community is actively debating its role in RWA tokenization and its potential to serve as the critical bridge for TradFi, while concurrently navigating broader market volatility and speculation regarding future regulatory impacts.

Rayls is a Layer-1 blockchain ecosystem designed for financial institutions to bridge traditional finance (TradFi) and decentralized finance (DeFi). Developed by Parfin, Rayls combines a public chain, private networks, and institutional privacy nodes into a unified infrastructure that supports compliant, scalable, and privacy-preserving asset tokenization and settlement. Its architecture connects regulated banks and payment systems with public DeFi liquidity while maintaining confidentiality through the Rayls Enygma privacy protocol. The network enables tokenization of real-world assets, CBDCs, and stablecoins using EVM-compatible technology, fixed USD-pegged gas fees, deterministic finality, and harmful MEV protection.

Rayls

Rayls is generating significant community conversation as investors speculate on its potential for institutional adoption in the RWA space following its recent listing on major exchanges. While some participants are actively buying on perceived price bottoms, others are debating whether the volatility and recent volume patterns signal an imminent breakout or indicate a lack of long-term stability.

Compass Pathways Plc is a biotechnology company, which provides mental health care services. It focuses on improving the lives of those who are suffering with mental health challenges and who are not helped by current treatments. The company was founded by Goldsmith George Jay and Malievskaia Ekaterina in 2016 and is headquartered in London, the United Kingdom.

Compass Pathways Plc - ADR

COMPASS Pathways

COMPASS Pathways is trending following a presidential executive order designed to fast-track FDA reviews and expand research funding for psychedelic therapies. The community is actively discussing the stock's potential for clinical acceleration, with many focused on its status as one of the few players to successfully complete two Phase 3 trials and its positioning for upcoming regulatory catalysts.

SPDR Gold Trust - SPDR Gold Shares

SPDR Gold Shares ETF

SPDR Gold Shares (GLD) is trending as investors weigh geopolitical risks in the Strait of Hormuz against hopes for a ceasefire, prompting discussions on whether the asset is regaining its traditional role as a safe-haven hedge. Market participants are closely analyzing options flow and institutional positioning to gauge if gold's recent price action signals a broader flight to quality amid persistent concerns over inflation and energy supply shocks.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Eli Lilly in advanced talks to acquire Kelonia Therapeutics for over $2 billion, WSJ says

A deal could be reached as soon as Monday and could include additional payments tied to Kelonia meeting certain milestones, The Wall Street Journal reported...

Best Medical Stocks To Research - April 19th

UnitedHealth Group, Eli Lilly and Company, and Johnson & Johnson are the three Medical stocks to watch today, according to MarketBeat's stock screener tool. Medical stocks are shares of publicly traded companies that develop, manufacture, distribute, or provide services related to healthcare incl...

Pharmaceutical Stocks To Consider - April 19th

Eli Lilly and Company, AbbVie, Abbott Laboratories, Gilead Sciences, Pfizer, McKesson, and Bristol Myers Squibb are the seven Pharmaceutical stocks to watch today, according to MarketBeat's stock screener tool. Pharmaceutical stocks are shares of publicly traded companies that research, develop, ma...

Diversified Management Inc. Invests $2.20 Million in Eli Lilly and Company $LLY

Diversified Management Inc. bought a new stake in shares of Eli Lilly and Company (NYSE:LLY - Free Report) in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund bought 2,050 shares of the company's stock, valued at approximate...

Pursue Wealth Partners LLC Acquires New Stake in Eli Lilly and Company $LLY

Pursue Wealth Partners LLC acquired a new stake in Eli Lilly and Company (NYSE:LLY - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor acquired 2,136 shares of the company's stock, valued at approximately $2,296,000. Eli Lilly an...

KBC Group NV Has $756.59 Million Stake in Eli Lilly and Company $LLY

KBC Group NV lifted its stake in Eli Lilly and Company (NYSE:LLY - Free Report) by 1.8% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 704,017 shares of the company's stock after acquiring an additional 12,127 shares...

Lbp Am Sa Buys 9,107 Shares of Eli Lilly and Company $LLY

Lbp Am Sa grew its stake in shares of Eli Lilly and Company (NYSE:LLY - Free Report) by 4.2% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 224,166 shares of the company's stock after purchasing an additional 9,107 share...

Foster Victor Wealth Advisors LLC Purchases 1,127 Shares of Eli Lilly and Company $LLY

Foster Victor Wealth Advisors LLC lifted its position in shares of Eli Lilly and Company (NYSE:LLY - Free Report) by 94.5% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 2,319 shares of the company's...

Eli Lilly and Company $LLY Shares Acquired by Border to Coast Pensions Partnership Ltd

Border to Coast Pensions Partnership Ltd lifted its holdings in Eli Lilly and Company (NYSE:LLY - Free Report) by 11.5% in the fourth quarter, according to its most recent disclosure with the SEC...

Pharmaceutical Stocks To Follow Now - April 18th

Eli Lilly and Company, AbbVie, Abbott Laboratories, Gilead Sciences, Pfizer, McKesson, and Bristol Myers Squibb are the seven Pharmaceutical stocks to watch today, according to MarketBeat's stock screener tool. Pharmaceutical stocks are shares of publicly traded companies whose primary business is...

LLY
Lilly(Eli) & Co

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest LLY News

LLYLilly(Eli) & Co